John Overdeck’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$594K Sell
8,945
-316,195
-97% -$26.8M ﹤0.01% 4026
2026
Q1
$32.3M Sell
325,140
-110,829
-25% -$14.5M 0.03% 688
2025
Q4
$53M Sell
435,969
-199,425
-31% -$25M 0.07% 331
2025
Q3
$71.3M Buy
635,394
+223,409
+54% +$26.2M 0.11% 248
2025
Q2
$55.2M Buy
411,985
+389,280
+1,715% +$42.7M 0.1% 266
2025
Q1
$1.53M Buy
22,705
+10,182
+81% +$700K ﹤0.01% 1913
2024
Q4
$781K Buy
+12,523
New +$1.17M ﹤0.01% 2324
2023
Q4
Sell
-14,100
Closed -$772K 3385
2023
Q3
$772K Hold
14,100
﹤0.01% 2072
2023
Q2
$1.18M Buy
14,100
+1,562
+12% +$120K ﹤0.01% 1847
2023
Q1
$950K Sell
12,538
-35,910
-74% -$2.48M ﹤0.01% 1894
2022
Q4
$2.99M Sell
48,448
-34,238
-41% -$1.82M 0.01% 1111
2022
Q3
$3.45M Buy
+82,686
New +$3.6M 0.01% 904
2022
Q1
Sell
-53,900
Closed -$1.03M 4262
2021
Q4
$1.03M Buy
53,900
+12,400
+30% +$311K ﹤0.01% 2542
2021
Q3
$1.37M Sell
41,500
-58,200
-58% -$1.78M ﹤0.01% 2321
2021
Q2
$3.31M Buy
99,700
+62,000
+164% +$1.72M 0.01% 1477
2021
Q1
$1.56M Buy
+37,700
New +$1.16M ﹤0.01% 1900

Other funds holding TMDX

John Overdeck's TMDX Position: Q2 2026 in Review

John Overdeck reduced its Transmedics (TMDX) stake by 97% in Q2 2026, selling an estimated $26.8M and leaving 8,945 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

John Overdeck first reported a position in TMDX in Q1 2021 and has held it in 16 quarters since. The position peaked at $71.3M in Q3 2025. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • John Overdeck held 8,945 shares of Transmedics worth $594K as of Q2 2026.
  • John Overdeck sold 316,195 Transmedics shares in Q2 2026, an estimated $26.8M.
  • Transmedics made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4026 holding.
  • John Overdeck first reported a position in Transmedics in Q1 2021 and has held it in 16 quarters since.
  • John Overdeck's Transmedics position peaked at $71.3M in Q3 2025.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.